secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001493152-24-024224
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma names Timothy Lorber as CFO; Vander Hoek shifts to VP Regulatory
-------------------------------------------------------------------------------

- Timothy Lorber, CPA with 40+ years experience, appointed CFO; part-time until Sept 9, 2024, then full-time from Sept 10, 2024.
- Lorber receives $227k annual base salary; 227,635 RSUs vesting over 3 years; eligible for up to $72k milestone bonus.
- Current CFO Michael Vander Hoek transitions to full-time Vice President, Regulatory concurrent with Lorber's full-time appointment.
- Vander Hoek had served as both CFO and VP Regulatory for past four years; will now focus on regulatory matters for Phase 2 trial.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224024224/0001493152-24-024224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224024224/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer